Agilon Health AGL Income Statement (2020-2026)

NYSE AGL
$86.34 -1.04 (-1.19%)
As of: Sep 3, 2026 · 3:59 PM EDT
Reported Financials

Agilon Health Quarterly Income Statement

Periods 26 quarters
Latest Jun 2026

Agilon Health reported revenue of $1494.74M and net income of $17.96M for the quarter ended Jun 2026, up 7.2% year over year. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
458.61M150.82M653.45M670.13M694.86M369.78M1,054.31M1,069.12M1,136.86M1,056.07M1,604.35M1,482.76M1,450.93M1,522.49M1,532.78M1,394.98M1,435.32M1,569.49M1,420.46M1,494.74M
Cost of RevenueCost of Rev
414.20M140.29M566.21M587.14M618.29M322.23M897.57M932.82M1,022.87M1,155.39M1,443.84M1,374.06M1,505.95M1,518.68M1,401.87M1,445.24M1,489.48M1,641.32M1,269.63M1,296.23M
Gross Profit
10.53M47.56M156.74M136.29M113.99M-99.32M160.51M108.70M-55.02M3.81M130.91M-50.26M-54.16M-71.82M150.83M198.51M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
0.60M0.50M0.70M0.60M1.40M1.20M1.70M1.80M2.10M-3.80M2.80M2.90M3.10M-7.20M3.80M3.90M3.80M-10.00M
Selling, General & AdministrativeSG&A
46.64M25.52M39.83M51.92M51.98M64.05M69.75M79.25M72.06M64.70M76.42M69.61M63.12M59.76M65.96M56.28M56.20M60.10M54.23M88.50M
Other Operating ExpensesOther Opex
446.97M150.96M613.65M-5.46M982.44M1,532.31M1,518.22M1,578.03M1,485.14M1,450.83M1,506.60M1,713.21M1,362.23M1,394.47M
Operating ExpensesOpex
494.21M176.98M654.19M691.19M724.38M423.85M1,053.89M1,098.07M1,176.16M1,220.37M1,611.53M1,526.10M1,584.44M1,630.59M1,554.89M1,511.01M1,566.60M1,763.32M1,416.46M1,482.97M
Operating IncomeOp. Inc
-35.60M-26.16M-0.74M-21.05M-29.52M-54.06M0.42M-28.96M-39.29M-164.30M-7.18M-43.34M-133.51M-108.10M-22.11M-116.03M-131.27M-193.82M4.00M11.77M
EBIT
-35.60M-26.16M-0.74M-21.05M-29.52M-54.06M0.42M-28.96M-39.29M-164.30M-7.18M-43.34M-133.51M-108.10M-22.11M-116.03M-131.27M-193.82M4.00M11.77M
Non-operating items
Non Operating Interest Expenses
0.87M0.84M0.87M0.94M1.00M1.67M1.49M1.55M1.62M1.99M1.28M1.70M1.62M1.57M1.51M1.57M1.84M1.72M1.81M1.61M
Non Operating IncomeNon Op. Inc.
-0.27M-1.86M2.27M7.00M4.89M7.56M7.89M7.09M5.42M7.44M5.89M4.84M16.06M7.70M9.26M7.88M9.44M41.03M16.02M15.02M
Net income details
EBT
-36.74M-35.62M0.66M-20.46M-29.94M-40.92M8.19M-14.95M-20.83M-166.87M3.11M-30.25M-117.02M-104.67M-1.69M-104.31M-110.54M-187.56M29.94M17.58M
Tax ProvisionsTaxes
0.26M0.18M-0.07M0.58M0.56M0.57M-1.76M1.07M1.21M0.27M-0.13M0.42M-0.59M1.76M0.20M0.06M-0.33M1.32M0.03M-0.38M
Profit After TaxPAT
-36.99M-56.74M1.23M-21.04M-30.74M-56.05M16.02M-16.80M-31.48M-230.48M-6.06M-30.68M-117.61M-105.79M12.11M-104.37M-110.21M-188.88M48.92M17.96M
Equity Income
-4.31M7.25M1.38M8.47M14.66M-8.02M5.68M9.96M2.05M-2.69M12.67M5.41M13.13M-33.05M11.73M-7.60M
Income from Non-Controlling InterestsInc. Minority
0.12M-0.58M0.07M-0.08M-0.07M-0.08M-0.06M-0.05M-0.05M-0.05M0.03M0.02M
Income from Continuing OperationsIncome (Continuing)
-36.99M-35.80M0.73M-21.04M-30.50M-41.49M9.95M-16.03M-22.04M-167.14M3.25M-30.66M-116.43M-106.43M-1.89M-104.37M-110.21M-188.88M29.92M17.96M
Income from Discontinued OperationsIncome (Discontinued)
1.12M-20.67M0.43M0.32M-0.24M-15.08M6.01M-0.77M-9.44M-63.34M-9.28M-1.18M0.64M14.00M19.00M
Consolidated Net IncomeConsol Net Inc.
-35.88M-56.47M1.16M-20.72M-30.74M-56.58M15.96M-16.80M-31.48M-230.48M-6.03M-30.66M-117.61M-105.79M12.11M-104.37M-110.21M-188.88M48.92M17.96M
Income towards Parent CompanyParent Net Inc
-35.88M-56.47M1.16M-20.72M-30.74M-56.58M15.96M-16.80M-31.48M-230.48M-6.03M-30.66M-117.61M-105.79M12.11M-104.37M-110.21M-188.88M48.92M17.96M
Net Income towards Common StockholdersNet Income
-35.88M-56.47M1.16M-20.72M-30.74M-56.58M15.96M-16.80M-31.48M-230.48M-6.03M-30.66M-117.61M-105.79M12.11M-104.37M-110.21M-188.88M48.92M17.96M
Additional items
EPS (Basic)
-2.29-3.790.07-1.27-1.87-3.470.97-1.02-1.94-14.09-0.37-1.86-7.14-6.440.73-6.31-6.65-11.412.951.07
EPS (Diluted)
-2.29-3.790.07-1.27-1.87-3.470.94-1.02-1.94-14.09-0.36-1.86-7.14-6.440.73-6.31-6.65-11.412.941.04
Shares Outstanding
15.65M14.92M16.08M16.29M16.44M16.33M16.53M16.41M16.23M16.36M16.36M16.45M16.46M16.44M16.52M16.55M16.58M16.56M16.60M16.70M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
15.65M14.92M16.96M16.29M16.44M16.33M17.06M16.41M16.23M16.36M16.54M16.45M16.46M16.44M16.52M16.55M16.58M16.56M16.66M17.21M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
15.66M16.00M16.23M16.33M16.47M16.50M16.58M16.22M16.24M16.26M16.43M16.46M16.48M16.49M16.52M16.57M16.58M16.59M16.61M16.79M
EBITDA
-35.00M-25.66M-0.04M-20.45M-28.12M-52.87M2.12M-27.16M-37.19M-168.10M-4.38M-40.44M-130.41M-115.30M-18.31M-112.13M-127.47M-203.82M4.00M11.77M
Interest ExpensesInt Expense
0.87M0.84M0.87M0.94M1.00M1.67M1.49M1.55M1.62M1.99M1.28M1.70M1.62M1.57M1.51M1.57M1.84M1.72M1.81M1.61M
Tax Rate
-0.70%-0.50%-10.84%-2.84%-1.87%-1.40%-21.47%-7.18%-5.81%-0.16%-4.27%-1.38%0.50%-1.68%-11.58%-0.06%0.30%-0.71%0.09%-2.13%